Literature DB >> 7760805

c-Myb and core-binding factor/PEBP2 display functional synergy but bind independently to adjacent sites in the T-cell receptor delta enhancer.

C Hernandez-Munain1, M S Krangel.   

Abstract

A T-cell-specific transcriptional enhancer lies within the J delta 3-C delta intron of the human T-cell receptor delta gene. We have previously shown that a 30-bp element, denoted delta E3, acts as the minimal TCR delta enhancer and that within delta E3, adjacent and precisely spaced binding sites for core-binding factor (CBF/PEBP2) and c-Myb are essential for transcriptional activity. These data suggested that CBF/PEBP2 and c-Myb synergize to mediate transcriptional activity but did not establish the molecular basis for synergy. In this study, we have examined in detail the binding of CBF/PEBP2 and c-Myb to delta E3. We found that CBF/PEBP2 and c-Myb could simultaneously occupy the core site and one of two overlapping Myb sites within delta E3. However, equilibrium binding and kinetic dissociation experiments suggest that the two factors bind to delta E3 independently, rather than cooperatively. This was found to be true by using isoforms of these factors present in extracts of transfected COS-7 cells, as well as the natural factors present in nuclear extracts of the Jurkat T-cell line. We further showed that CBF/PEBP2 and c-Myb provide unique transactivation functions, since the core-Myb combination cannot be substituted by dimerized core or Myb sites. We propose that spatially precise synergy between CBF/PEBP2 and c-Myb may result from the ability of the two factors to form a composite surface that makes unique and stereospecific contacts with one or more additional components of the transcriptional machinery.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7760805      PMCID: PMC230540          DOI: 10.1128/MCB.15.6.3090

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  70 in total

1.  Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt.

Authors:  P Erickson; J Gao; K S Chang; T Look; E Whisenant; S Raimondi; R Lasher; J Trujillo; J Rowley; H Drabkin
Journal:  Blood       Date:  1992-10-01       Impact factor: 22.113

Review 2.  Transcriptional regulation of T-cell genes during T-cell development.

Authors:  J M Leiden; C B Thompson
Journal:  Curr Opin Immunol       Date:  1994-04       Impact factor: 7.486

3.  Transactivation and transformation by Myb are negatively regulated by a leucine-zipper structure.

Authors:  C Kanei-Ishii; E M MacMillan; T Nomura; A Sarai; R G Ramsay; S Aimoto; S Ishii; T J Gonda
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

4.  PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2 beta/CBF beta proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells.

Authors:  I Nuchprayoon; S Meyers; L M Scott; J Suzow; S Hiebert; A D Friedman
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

5.  c-Myb-induced trans-activation mediated by heat shock elements without sequence-specific DNA binding of c-Myb.

Authors:  C Kanei-Ishii; T Yasukawa; R I Morimoto; S Ishii
Journal:  J Biol Chem       Date:  1994-06-03       Impact factor: 5.157

6.  PEBP2 alpha B/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials.

Authors:  S C Bae; E Ogawa; M Maruyama; H Oka; M Satake; K Shigesada; N A Jenkins; D J Gilbert; N G Copeland; Y Ito
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

7.  Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia.

Authors:  K Mitani; S Ogawa; T Tanaka; H Miyoshi; M Kurokawa; H Mano; Y Yazaki; M Ohki; H Hirai
Journal:  EMBO J       Date:  1994-02-01       Impact factor: 11.598

8.  Regulation of the expression of the hematopoietic stem cell antigen CD34: role of c-myb.

Authors:  P Melotti; D H Ku; B Calabretta
Journal:  J Exp Med       Date:  1994-03-01       Impact factor: 14.307

9.  Enhancer-dependent and -independent steps in the rearrangement of a human T cell receptor delta transgene.

Authors:  P Lauzurica; M S Krangel
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

10.  Temporal and lineage-specific control of T cell receptor alpha/delta gene rearrangement by T cell receptor alpha and delta enhancers.

Authors:  P Lauzurica; M S Krangel
Journal:  J Exp Med       Date:  1994-06-01       Impact factor: 14.307

View more
  35 in total

1.  Disruption of hematopoiesis and thymopoiesis in the early premalignant stages of infection with SL3-3 murine leukemia virus.

Authors:  Karen Rulli; Jack Lenz; Laura S Levy
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

2.  Core binding factor cannot synergistically activate the myeloperoxidase proximal enhancer in immature myeloid cells without c-Myb.

Authors:  M Britos-Bray; A D Friedman
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

3.  c-Myb binds to a sequence in the proximal region of the RAG-2 promoter and is essential for promoter activity in T-lineage cells.

Authors:  Q F Wang; J Lauring; M S Schlissel
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

Review 4.  Recent insights into the transcriptional control of the Tcra/Tcrd locus by distant enhancers during the development of T-lymphocytes.

Authors:  Cristina Hernández-Munain
Journal:  Transcription       Date:  2015

5.  Increased induction of osteopetrosis, but unaltered lymphomagenicity, by murine leukemia virus SL3-3 after mutation of a nuclear factor 1 site in the enhancer.

Authors:  S Ethelberg; B D Tzschaschel; A Luz; S J Diaz-Cano; F S Pedersen; J Schmidt
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

Review 6.  Developmental relationship between hematopoietic and endothelial cells.

Authors:  Jesse J Lugus; Changwon Park; Kyunghee Choi
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

7.  The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription.

Authors:  S W Hiebert; W Sun; J N Davis; T Golub; S Shurtleff; A Buijs; J R Downing; G Grosveld; M F Roussell; D G Gilliland; N Lenny; S Meyers
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

8.  Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo.

Authors:  S Ethelberg; J Lovmand; J Schmidt; A Luz; F S Pedersen
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

9.  CBF, Myb, and Ets binding sites are important for activity of the core I element of the murine retrovirus SL3-3 in T lymphocytes.

Authors:  A L Zaiman; A Nieves; J Lenz
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

10.  Transcriptional activation of a retrovirus enhancer by CBF (AML1) requires a second factor: evidence for cooperativity with c-Myb.

Authors:  A L Zaiman; J Lenz
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.